Skip to main content

Canakinumab for Juvenile Idiopathic Arthritis User Reviews

Brand names: Ilaris

  • SJIA...
  • Taken for 1 to 6 months
  • April 16, 2022

Ilaris (canakinumab) "My daughter switched to this from daily Kineret and it treats the symptoms of systemic Juvenile idiopathic arthritis just as well but in once monthly injection."

10 / 10
Was this helpful?YesNo
0 Report

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.